Skip to content
DataLookout
Menu

Sleep SMARTNCT03812653

Sleep for Stroke Management and Recovery Trial

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 36 versions: 35 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Study sites: 116 to 148
  2. Notable Eligibility criteria expanded, about 18 words Show 6 more changesShow less
    • Trial completed
    • Final enrollment: 1892 participants (planned 3062)
    • Primary completion date changed from estimate of Nov 2026 to Jul 8, 2026
    • Secondary endpoints: details revised at 3 of 3 entries
    • Site details revised at 8 of 116 sites
    • Publications: details revised at 2 of 2 entries
  3. Minor Trial status: Recruiting to Active, Not Recruiting
    • Site details revised at 116 of 116 sites
    v33
  4. Minor Site details revised at 4 of 116 sitesv32
  5. Minor Site details revised at 8 of 116 sitesv31
Show 29 earlier versionsHide 29 earlier versions
  1. Minor Site details revised at 13 of 116 sitesv30
  2. Minor Site details revised at 14 of 116 sitesv29
  3. Minor Site details revised at 19 of 116 sitesv28
  4. Minor Study sites: 112 to 116v27
  5. Minor Site details revised at 107 of 112 sitesv26
  6. Minor Study sites: 110 to 112v25
  7. Minor Study sites: 111 to 110v24
  8. Notable Eligibility criteria expanded, about 30 words
    • Study sites: 112 to 111
    v23
  9. Minor Site details revised at 5 of 112 sitesv22
  10. Minor Study sites: 110 to 112v21
  11. Minor Study sites: 111 to 110v20
  12. Minor Study sites: 109 to 111v19
  13. Minor Site contacts updated at 4 of 109 sitesv18
  14. Minor Study sites: 110 to 109v17
  15. Notable Primary and study completion dates: Nov 2023 to Nov 2026
    • Study sites: 112 to 110
    v16
  16. Minor Study sites: 113 to 112v15
  17. Minor Study sites: 115 to 113v14
  18. Minor Study sites: 120 to 115v13
  19. Minor Study sites: 121 to 120v12
  20. Minor Study sites: 124 to 121v11
  21. Minor Study sites: 125 to 124v10
  22. Minor Study sites: 121 to 125v9
  23. Notable Trial status: Suspended to Recruiting
    • Site details revised at 121 of 121 sites
    v8
  24. Stopped Trial status: Recruiting to Suspended Sponsor's reason: Stopped until further notice due to COVID-19 restrictions
    • Study sites: 114 to 121
    v7
  25. Minor Study sites: 107 to 114v6
  26. Minor Study sites: 106 to 107v5
  27. Minor Study sites: 103 to 106v4
  28. Notable Trial status: Not Yet Recruiting to Recruiting
    • Eligibility criteria expanded, about 5 words
    • Study sites: 106 to 103
    • Start date changed from estimate of May 2019 to May 9, 2019
    v3
  29. Notable Start date: Mar 2019 to May 2019v2
  1. Study First Submitted
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Time to Event Combined Outcome: new ischemic stroke, acute coronary syndrome, or all-cause mortality
Timeframe: 6 months post randomization
Modified Rankin Scale Score
Timeframe: 3 months post randomization

Secondary (3)

NIH Stroke Score (NIHSS)
Short Montreal Cognitive Assessment (MoCA) Score
Quality of Life outcome

Arms and interventions

Intervention Arm: CPAP with Usual Care.Experimental

6 months of CPAP plus usual medical therapy.

Control Arm: Usual Care.No intervention

6 months of usual medical therapy alone.

Devices: CPAP

Sites

148 sites in 1 country